These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2633693)

  • 21. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic and biochemical control of biosynthesis of macrolide antibiotics].
    Navashin SM; Fedorenko VA; Nastasiak IN; Mironov VA; Kirichenko NV; Danilenko VN
    Antibiot Khimioter; 1990 Dec; 35(12):34-8. PubMed ID: 2078074
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuous culture of immobilized streptomyces cells for kasugamycin production.
    Kim CJ; Chang YK; Chun GT; Jeong YH; Lee SJ
    Biotechnol Prog; 2001; 17(3):453-61. PubMed ID: 11386865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
    Song JY; Jensen SE; Lee KJ
    Appl Microbiol Biotechnol; 2010 Oct; 88(3):659-69. PubMed ID: 20711575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of lipids isolated from mycelial waste during antibiotic production].
    Karpukhin VF; Iakubova AR; Konova IV; Pan'kina OI; Rakushina EV
    Antibiot Khimioter; 1991 Oct; 36(10):12-3. PubMed ID: 1805687
    [No Abstract]   [Full Text] [Related]  

  • 26. Production of a new antibacterial antibiotic from a mutated strain of Streptomyces kanamyceticus M27 in submerged fermentation.
    Mukherji B; Chattopadhyay P; Ray L
    Hindustan Antibiot Bull; 2005 Feb-2006 Nov; 47-48(1-4):1-6. PubMed ID: 18697724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primitive nature of secondary metabolism.
    Sermonti G
    Riv Biol; 1980; 73(3):353-71. PubMed ID: 7017884
    [No Abstract]   [Full Text] [Related]  

  • 28. Genome shuffling and ribosome engineering of Streptomyces actuosus for high-yield nosiheptide production.
    Wang Q; Zhang D; Li Y; Zhang F; Wang C; Liang X
    Appl Biochem Biotechnol; 2014 Jul; 173(6):1553-63. PubMed ID: 24828581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Controlled search for antibiotic producers among Actinomadura].
    Terekhova LP; Galatenko OA; Preobrazhenskaia TP
    Antibiot Khimioter; 1988 Dec; 33(12):930-4. PubMed ID: 3072931
    [No Abstract]   [Full Text] [Related]  

  • 30. [The search for new antibacterial antibiotics produced by rare genera of Actinomyces].
    Terekhova LP; Preobrazhenskaia TP; Galatenko OA
    Antibiot Khimioter; 1989 May; 34(5):390-5. PubMed ID: 2662931
    [No Abstract]   [Full Text] [Related]  

  • 31. Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.
    Niraula NP; Kim SH; Sohng JK; Kim ES
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1187-94. PubMed ID: 20508927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003.
    Thapa LP; Oh TJ; Liou K; Sohng JK
    J Appl Microbiol; 2008 Jul; 105(1):300-8. PubMed ID: 18355231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finetuning pristinamycin synthesis in streptomycetes.
    Hopwood D
    Nat Biotechnol; 1997 Apr; 15(4):321. PubMed ID: 9094127
    [No Abstract]   [Full Text] [Related]  

  • 34. A sandwich-culture technique for controlling antibiotic production and morphological development in Streptomyces coelicolor.
    de Jong IP; Claessen D
    J Microbiol Methods; 2012 Nov; 91(2):318-20. PubMed ID: 22995715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [All-Union seminar "Methods of controlled screening of antibiotics and other biologically active substances"].
    Ivanitskaia LP; Murygina VP
    Antibiot Khimioter; 1988 Dec; 33(12):883-7. PubMed ID: 2907722
    [No Abstract]   [Full Text] [Related]  

  • 36. [Design of Streptomyces nogalater LV65 strains with higher synthesis of nogalamicin using regulatory genes].
    Klimishin DA; Rabyk MV; Gren' TP; Nimets' OIa; Gonchar MA; Gromyko AN; Fedorenko VA
    Prikl Biokhim Mikrobiol; 2011; 47(6):650-4. PubMed ID: 22288193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of genetic engineering on the commercial production of antibiotics by Streptomyces and related bacteria.
    Hutchinson CR
    Appl Biochem Biotechnol; 1987; 16():169-90. PubMed ID: 3332755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering of regulatory cascades and networks controlling antibiotic biosynthesis in Streptomyces.
    Martín JF; Liras P
    Curr Opin Microbiol; 2010 Jun; 13(3):263-73. PubMed ID: 20303823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational biosynthesis of new antibiotics.
    Daum SJ; Lemke JR
    Annu Rev Microbiol; 1979; 33():241-65. PubMed ID: 386923
    [No Abstract]   [Full Text] [Related]  

  • 40. Developments in the use of Bacillus species for industrial production.
    Schallmey M; Singh A; Ward OP
    Can J Microbiol; 2004 Jan; 50(1):1-17. PubMed ID: 15052317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.